diff options
author | Petar Petrov <petar.petrov@student.oulu.fi> | 2015-04-11 22:39:24 +0700 |
---|---|---|
committer | Willy Sudiarto Raharjo <willysr@slackbuilds.org> | 2015-04-11 22:39:24 +0700 |
commit | d700c3eee3311aab6626f03e04e6e41befcd53fd (patch) | |
tree | 9c471b75afc09700f5d269a08f2395e733433157 /academic/finchtv/COMPANY | |
parent | 2a8cbdbdf9b424b624cc92e9cfde29812e60b427 (diff) | |
download | slackbuilds-d700c3eee3311aab6626f03e04e6e41befcd53fd.tar.gz |
academic/finchtv: Added (Brilliant Trace Viewer).
Signed-off-by: Willy Sudiarto Raharjo <willysr@slackbuilds.org>
Diffstat (limited to 'academic/finchtv/COMPANY')
-rw-r--r-- | academic/finchtv/COMPANY | 51 |
1 files changed, 51 insertions, 0 deletions
diff --git a/academic/finchtv/COMPANY b/academic/finchtv/COMPANY new file mode 100644 index 0000000000..702989c3ce --- /dev/null +++ b/academic/finchtv/COMPANY @@ -0,0 +1,51 @@ +About Geospiza (http://www.geospiza.com/Company/default.shtml) + +Geospiza is a leading developer of enterprise-class software systems +for workflow management of genetic analysis. + +Geospiza has established itself as the life science industry’s top +software developer for meeting the combined laboratory, data +management and analytical needs of biotechnology and pharmaceutical +companies, universities, researchers, contract core and diagnostic +laboratories involved in genetic testing and manufacturing bio- +therapeutics. + +The life sciences field is rapidly evolving beyond sequencing genomes +for pure research to developing clinically relevant initiatives such +as understanding what genetic information is useful for drug +development, determining drug efficacy, toxicity screening and +diagnosing infectious agents. + +This expansion of the field is resulting in a dramatic increase in the +amount of data that must be managed by genetic testing laboratories +and research institutions. Underscoring this growth is the desire by +the Food & Drug Administration (FDA) and the broader healthcare +community to match drugs more specifically to a person's individual +genetic profile. The FDA is expected to focus on the sensitivity and +accuracy of these new diagnostics, thereby increasing the need for +verifiable, repeatable processes for testing. + +Today, the amount of manual work required to manage and make sense of +the vast amounts of genetic information being generated by clinical +and life science research laboratories worldwide is tremendous. In +order to be able to scale to meet this increased demand and scrutiny +in a cost-effective way, automated solutions are required. + +Geospiza makes software for crunching the vast amounts of genetic +data. When a laboratory uses GeneSifter Lab Edition, they are able to +significantly increase capacity, reduce their backlog, eliminate +errors due to manual processes, and speed time to discovery. The +software is being used today worldwide by leading institutions and +laboratories for everything from clinical DNA testing and bio- +therapeutic manufacturing to contract core lab services and basic +research and discovery. + +Geospiza's products are designed and built by biologists, enabling +researchers to focus on the science, not the software. + + +More Information +info.geospiza@perkinelmer.com +Call (206) 633-4403. + +©Copyright 2013 PerkinElmer, Inc. All rights reserved. |